Find Legal Topics > Drugs Laws > Kytril Lawsuit

Kytril Lawsuit

 

A brief guide to filing a Kytril lawsuit

 

The prescription medication Kytril alleviates nausea and vomiting for patients taking chemotherapy treatment. Kytril side effects are uncommon and have not been reported to lead to any fatalities. At this time, most lawyers are not actively pursuing the opportunity to handle a Kytril lawsuit due to the drug's relatively safety.

 

However, two significant legal actions have been taken against the drug in the past. In 2007, a federal Kytril lawsuit reached a settlement resolution concerning manufacturer fraud in raising the wholesale price. These charges did not relate to Kytril side effects in any way. Instead, GlaxoSmithKline set aside 30% of a $70 million settlement negotiated during this Kytril lawsuit to compensate consumers who had been overcharged between 1991 and the first day of 2005. Claims for compensation were processed and resolved by 2009.

 

A 2004 Kytril lawsuit reached a conclusion the following year. A GlaxoSmithKline plant based in Puerto Rico was found guilty in 2010 of having regularly manufactured medication incorrectly. Though no Kytril side effects were reported as the result of consuming medication with too much or not enough of the active ingredient, the company was fined heavily for fraudulent sales of defective medication from 2001 to 2004. All settlement money relating to this Kytril lawsuit has been disbursed.

 

None of this litigation concerned Kytril side effects. Subsequently, no significant Kytril lawsuit has been reported concerning these issues. The primary serious Kytril side effects to be alert for are any reaction of an allergic reaction. The prescription medication provided by the manufacturer has not been updated since FDA approval was granted in 1993 to warn of other significant risks associated with treatment.

 

Patients who consumed some of the medication assembled at the defective plant may not have made the connection at the time between their adverse response and drug intake. However, even though the FDA only concluded its lawsuit against the manufacturer, the statute of limitations in your state probably precludes filing a Kytril lawsuit concerning adverse responses occurring between 2001 and 2004.

 

It is possible that further manufacturer defects may lead to similar cases or recalls in the future. If so, consumers who experience adverse effects will need to provide copies of their prescription purchase receipt to demonstrate that their medication came from a compromised or tainted batch.

 

Serious Kytril side effects not warned against in the medication should be reported to the FDA. If enough such incidents are reported, they may prompt a safety review of the medication. However, at this time the FDA is not pursuing an investigation regarding potentially serious and underreported Kytril side effects.

 

If such an event occurs, it is important to make sure that all complications are documented by a medical professional. Thorough documentation of Kytril side effects will be a prerequisite for an attorney to consider whether litigation stands a realistic chance of resulting in financial compensation. Such an evaluation can only be made by a pharmaceutical attorney experienced in handling similar cases.

 

Related Topics